BofA/Merrill Lynch analyst, Kevin Fischbeck, reiterated his Buy rating on shares of Aetna (NYSE: AET) after the company's investor day ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE